We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Power Integrations
POWI
$3.54B
| $1.75M | 0.25% |
+70,566
| New | +$1.62M |
|
|
ANK
102
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
| $1.75M | 0.25% |
+23,101
| New | +$1.75M |
|
|
CHMT
103
DELISTED
Chemtura Corporation
CHMT
| $1.73M | 0.25% |
65,558
+8,002
| +14% | +$204K |
|
104
RadNet
RDNT
$4.84B
| $1.71M | 0.25% |
353,078
+5,486
| +2% | +$30.5K |
|
105
Boyd Gaming
BYD
$6.47B
| $1.7M | 0.25% |
82,304
+66,487
| +420% | +$1.18M |
|
|
EPZM
106
DELISTED
Epizyme, Inc
EPZM
| $1.68M | 0.24% |
138,889
+64,189
| +86% | +$649K |
|
|
BGC
107
DELISTED
General Cable Corporation
BGC
| $1.67M | 0.24% |
136,917
-238,787
| -64% | -$2.43M |
|
108
Columbus McKinnon
CMCO
$465M
| $1.66M | 0.24% |
+105,176
| New | +$1.56M |
|
109
KBR
KBR
$4.68B
| $1.65M | 0.24% |
+106,859
| New | +$1.51M |
|
110
Matrix Service
MTRX
$347M
| $1.64M | 0.24% |
92,854
+75,673
| +440% | +$1.37M |
|
|
PRAH
111
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.64M | 0.24% |
+38,456
| New | +$1.62M |
|
112
Axcelis
ACLS
$4.12B
| $1.64M | 0.24% |
146,733
-236,578
| -62% | -$2.42M |
|
113
MacroGenics
MGNX
$235M
| $1.63M | 0.23% |
86,649
-28,686
| -25% | -$546K |
|
|
EMKR
114
DELISTED
Emcore Corp
EMKR
| $1.62M | 0.23% |
32,323
+13,716
| +74% | +$746K |
|
115
CACI
CACI
$10.8B
| $1.61M | 0.23% |
+15,126
| New | +$1.41M |
|
116
Caleres
CAL
$396M
| $1.61M | 0.23% |
56,991
-1,428
| -2% | -$38K |
|
|
SRGA
117
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.61M | 0.23% |
13,386
+7,310
| +120% | +$768K |
|
118
Cavco Industries
CVCO
$4.39B
| $1.6M | 0.23% |
17,072
-1,175
| -6% | -$96.7K |
|
119
Methode Electronics
MEI
$543M
| $1.6M | 0.23% |
+54,588
| New | +$1.48M |
|
120
Koppers
KOP
$966M
| $1.59M | 0.23% |
70,923
-200,295
| -74% | -$3.57M |
|
121
Monarch Casino & Resort
MCRI
$2.14B
| $1.57M | 0.23% |
80,913
-6,279
| -7% | -$126K |
|
|
BV
122
DELISTED
Bazaarvoice, Inc.
BV
| $1.57M | 0.23% |
497,923
+345,700
| +227% | +$1.17M |
|
123
Stepan Co
SCL
$1.31B
| $1.56M | 0.23% |
28,243
-60,070
| -68% | -$2.89M |
|
124
A10 Networks
ATEN
$2.47B
| $1.55M | 0.22% |
261,424
+116,528
| +80% | +$695K |
|
|
BEAT
125
DELISTED
BioTelemetry, Inc.
BEAT
| $1.55M | 0.22% |
132,510
+115,555
| +682% | +$1.29M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.